Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0166645 TREATMENT OF COLLAGEN DEFECTS USING PROTEIN SOLUTIONS
Methods of stimulating collagen production, including stimulation of chondrocyte production, at the site of a defect. Methods include administering to the site...
2016/0166644 MODULATING APOPTOSIS
The use and screening of modulators of apoptosis is disclosed. The modulators may be, for example, modulator of NF-.kappa.B activity. The modulators may be...
2016/0166643 USE OF NRF2 INDUCERS TO TREAT EPIDERMOLYSIS BULLOSA SIMPLEX AND RELATED DISEASES
The present invention relates to methods and compositions for the prevention and treatment of keratin-based skin diseases. In particular, the application...
2016/0166642 USES AND METHODS FOR MODULATING BILE ACID HOMEOSTASIS AND TREATMENT OF BILE ACID DISORDERS AND DISEASES
The invention relates to variants and fusions of fibroblast growth factor 19 (FGF19), variants and fusions of fibroblast growth factor 21 (FGF21), fusions of...
2016/0166641 METHOD OF TREATING PERIPHERAL NERVE DISORDERS
The invention relates to the use of agents that bind the complement protein C5 in the treatment of diseases associated with inappropriate complement...
2016/0166640 METHOD OF TREATING MYASTHENIA GRAVIS
The invention relates to the use of agents that bind the complement protein C5 in the treatment of diseases associated with inappropriate complement activation...
2016/0166639 GLYCOSYLATED PACAP/VIP ANALOGUES WITH ENHANCED CNS PENETRATION FOR TREATMENT OF NEURODEGENERATIVE DISEASES
A glycosylated pleiotropic peptide pituitary adenylate cyclase-activating polypeptide (PACAP) which can both agonize PAC.sub.1 receptors, causing ...
2016/0166638 LACTOFERRIN-OSTEOPONTIN-IRON COMPLEX
The present invention relates to complexes of lactoferrin, osteopontin and iron. In particular the invention relates to a composition comprising at least 2...
2016/0166637 METHODS OF TREATING A CANCER THROUGH TARGETED DISRUPTION OF ALPHA CONNEXIN 43-ZONULA OCCLUDENS-1 (ZO-1) INTERACTION
The present disclosure describes methods of treating a cancer based on the targeted disruption of alpha connexin 43-zonula occludens-1 (ZO-1) interaction. The...
2016/0166636 MODIFIED PEPTIDES AND THEIR USE FOR TREATING CHRONIC INFLAMMATORY DISEASES
The present invention relates to a peptide, or a salt thereof, comprising or consisting of the amino acid sequence IHMVYSKRSGKPRGYAFIEY, comprising one or more...
2016/0166635 PHARMACEUTICAL CYCLOSPORIN COMPOSITIONS
An oral cyclosporin composition comprises minicapsules having a core containing a cyclosporin, especially cyclosporin A in a solubilised liquid form. The...
2016/0166634 BIOCONJUGATES OF SYNTHETIC APELIN POLYPEPTIDES
The invention provides a bioconjugates comprising a synthetic polypeptide of Formula I' (SEQ ID NO: 1): ##STR00001## or an amide, an ester or a salt thereof,...
2016/0166633 METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF FRIEDREICH'S ATAXIA
The disclosure provides methods of preventing or treating Friedreich's ataxia in a mammalian subject, reducing risk factors, signs and/or symptoms associated...
2016/0166632 PEPTIDE EPOXYKETONE PROTEASOME INHIBITORS IN COMBINATION WITH PIM KINASE INHIBITORS FOR TREATMENT OF CANCERS
This disclosure provides methods of treating a cancer in a patient using a peptide epoxyketone proteasome inhibitor in combination with a PIM kinase inhibitor.
2016/0166631 NUTRACEUTICAL COMBINATION FOR PREVENTION AND TREATMENT OF TYPE 2 DIABETES
A dietary supplement in capsule or tablet form includes a source of zinc in an amount equivalent to 6 mg to 40 mg of zinc chloride; optionally a source of...
2016/0166630 A COMPOSITION HAVING A PREBIOTIC EFFECT
Provided are food, dietary supplements and/or drug compositions having prebiotic effect and their use in human and animal care.
2016/0166629 PLANT EXTRACTS FOR IMPROVING COGNITIVE FUNCTION
Extracts of plants of the Lamiaceae family, including the Mentha genus, are shown to have a positive impact on overall cognitive health, including improvements...
2016/0166628 SKIN CARE COMPOSITION
The invention relates to a composition that provides enhanced macro/microcirculation when applied on skin or is ingested. This composition has applications in...
2016/0166627 JOINT HEALTH COMPOSITIONS
Joint health compositions for maintaining mobility and cartilage and preventing osteoarthritis, one of the compositions comprises Fructus Corni, said...
2016/0166626 TOPICAL COMPOSITIONS AND METHODS FOR REDUCING OXIDATIVE STRESS
A composition for the topical application on a mammalian skin comprises one or more Brassica plant extracts selected from the group consisting of: Brassica...
2016/0166625 PHARMACEUTICAL METHOD FOR CANNABIS DISTRIBUTION AND AN AILMENT-TARGETED CANNABIS COMPOSITION
A method of dispensing cannabis is disclosed that includes providing a cannabis composition via a dispensary, the cannabis composition having an effective...
2016/0166624 ANTI-VIRAL COMPOSITIONS
Therapeutic and prophylactic compositions to treat and/or prevent common and recurrent viral infections. The compositions have broad-spectrum antiviral...
2016/0166623 AGARICUS BLAZEI MURILL EXTRACTS, METHODS FOR INHIBITING LEGUMAIN USING THE SAME, AND METHODS FOR TREATING...
Extracts of Agaricus blazei Murill have been found to have anti-tumor activity. In particular, a polar, high molecular weight fraction of an Agaricus blazei...
2016/0166622 PENTOSIDINE PRODUCTION INHIBITOR
A pentosidine production inhibitor including a lactic acid bacterium fermentation product as an active ingredient, which has a stronger action and a high...
2016/0166621 NON-CHEMOTHERAPEUTIC ANTIBIOTIC TREATMENT FOR INFECTIONS IN CATTLE
Compositions and methods for treating and/or preventing bacterial infections in animals such as bovines are provided. The compositions and methods utilize the...
2016/0166620 ENCAPSULATED CELLS FOR HORMONE REPLACEMENT THERAPY
A composition comprising microcapsules, the microcapsules containing both live mammalian ovarian granulosa cells and live mammalian ovarian theca cells, is...
2016/0166619 Treatment of Retinal Degeneration Using Progenitor Cells
Methods and compositions for treating and reducing retinal degeneration using progenitor cells and conditioned media from progenitor cells, such as...
2016/0166618 TREATMENT OF PAIN USING AMNION DERIVED ADHERENT CELLS
Provided herein are methods of treatment of an individual having pain, e.g., neuropathic pain, comprising administering to the individual a therapeutically...
2016/0166617 MACROMOLECULAR CLUSTERS OF CARDIAC STEM CELLS AND METHODS FOR MAKING AND USING THEM
In alternative embodiments, provided are macrocellular structures or artificially configured plurality of cells, the so-called "cardioclusters" as provided...
2016/0166616 COMPOSITIONS OF ACORBIC ACID AND BONE MORPHOGENETIC PROTEIN 4 (BMP-4) FOR CELL GROWTH AND USES RELATED THEREO
This disclosure relates to compositions comprising ascorbic acid and bone morphogenetic protein 4 (BMP-4) for growing cells and making tissues. In certain...
2016/0166615 Material for Treatment of Cerebral Infarction
A material for treatment of cerebral infarction ameliorates angiopathy at a cerebral infarction region and improves brain function. The material for treatment...
2016/0166614 TREATMENT OF GRAFT-VERSUS-HOST DISEASE
This present application describes a therapeutic agent for treating acute or chronic graft-versus-host disease using clonal marrow stem cells (cMSCs) as active...
2016/0166613 METHODS FOR CONTROLLED ELIMINATION OF THERAPEUTIC CELLS
The technology relates in part to methods for controlling elimination of therapeutic cells, for example, cells that express a chimeric antigen receptor. The...
2016/0166612 Human Monocyte Sub-Population for Treatment of Eye Diseases and Disorders
A monocyte subpopulation having a low relative amount, or substantially devoid, of CD3.sup.+ cells, CD19.sup.+ cells, CD56.sup.+ cells and optionally...
2016/0166611 METHOD OF PREPARING INJECTION SOLUTION
A method of preparing an injection solution includes: (1) storing a mixture of a blood sample and a divalent cation chelating agent at a temperature between 2...
2016/0166610 METHOD FOR PRODUCING AN OSTEOINDUCTIVE CALCIUM PHOSPHATE AND PRODUCTS THUS OBTAINED
The invention relates to a method for producing an osteoinductive calcium phosphate material, the method comprising the steps of providing a sintered calcium...
2016/0166609 IRON-BASED MONTMORILLONITE MEDICAMENT FOR TREATING HYPERPHOSPHATEMIA AND IRON-DEFICIENCY ANEMIA, AND...
It discloses an iron-based montmorillonite medicine for treating hyperphosphatemia and iron deficiency anaemia, and the preparation method thereof. The...
2016/0166608 METHODS OF TREATING CANCER WITH HIGH POTENCY LIPID-BASED PLATINUM COMPOUND FORMULATIONS ADMINISTERED...
One aspect of the invention relates to methods of treating cancer in a patient comprising administering intraperitoneally to a patient in need thereof a cancer...
2016/0166607 Onychomycosis Treatment Apparatus and Method
A system and method includes delivery of a redox gas solution to treat onychomycosis, wherein the redox gas solution comprises a reactive species dissolved in...
2016/0166606 METHODS FOR REDUCING ISCHEMIA-REPERFUSION INJURY
Provided herein are methods for reducing ischemia-reperfusion injury and/or microvascular obstructions by administering to the subject effective amounts of...
2016/0166605 THERAPEUTIC AGENT FOR A DISEASE ACCOMPANIED BY EPILEPTIFORM DISCHARGES
Provided is a therapeutic agent for a disease accompanied by epileptiform discharges, which is easily-handled, has a low side effect, and has a fast acting...
2016/0166604 Thiol-Sensitive Positive Inotropes
The present invention relates to methods for treating diastolic dysfunction or a disease, disorder or condition associated with diastolic dysfunction, methods...
2016/0166603 AGENT AND METHOD FOR TREATING HERPES
The invention relates to a therapeutic active substance combination comprising polyacrylic acid and 2-amino-2-methylpropanol for use as a drug, especially for...
2016/0166602 Food Supplement Composition
A dietary supplement for promoting increased vitality, supporting mood, improving heart health, improving immune strength, improving antioxidant balance,...
2016/0166601 RE-EPITHELIALIZING PHARMACEUTICAL COMPOSITIONS COMPRISING XANTHAN GUM
The present invention relates to the use of xanthan gum as re-epithelializing agent and, in particular, to a pharmaceutical formulation comprising xanthan gum...
2016/0166600 THERAPY-ENHANCING GLUCAN
This invention provides a method for introducing substances into cells comprising contacting a composition comprising orally administered beta-glucan with said...
2016/0166599 THERAPEUTIC AGENT FOR INFLAMMATORY DISEASES, CONTAINING ADENOSINE N1-OXIDE AS AN EFFECTIVE INGREDIENT
The present invention has an object to provide an effective and safe therapeutic agent for inflammatory diseases such as sepsis, hepatitis, and inflammatory...
2016/0166598 A METHOD FOR TREATING INFECTION, SEPSIS AND INJURY
The invention relates to a composition or method for treating at least one of infection, sepsis and injury or inducing a hypotensive state or a low pain or...
2016/0166597 2'-BRANCHED NUCLEOSIDES AND FLAVIVIRIDAE MUTATION
The present invention discloses a method for the treatment of Flaviviridae infection that includes the administration of a 2'-branched nucleoside, or a...
2016/0166596 PHOSPHORAMIDATE DERIVATIVES OF 5 - FLUORO - 2` - DEOXYURIDINE FOR USE IN THE TREATMENT OF CANCER
Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine are disclosed for use in the treatment of cancer, especially in the treatment of cancer where the...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.